News Regeneron chair Vagelos steps down at 93 Biopharma legend P. Roy Vagelos will step down as chairman of Regeneron Pharmaceuticals after 29 years in June, at the age of 93.
News Former Seagen CEO Siegall pops up at new biotech Siegall resigned from Seagen last year amid claims of domestic abuse, though was not charged.
News Pfizer’s Susan Rienow named new president of ABPI Appointment follows the exit of Novo Nordisk's Pinder Sahota, after firm's ABPI code breaches.
News Reed pops up at J&J after leaving Sanofi Straight after John Reed's Sanofi exit, he has reappeared as head of pharma R&D at J&J
News Bill Anderson will replace Baumann as Bayer CEO Just weeks after Roche pharma chief Bill Anderson resigned to seek other opp
News Naoki Okamura named as next CEO of Astellas Kenji Yasukawa is stepping down as chief executive of Japanese pharma group Astellas, to be succeeded by Naoki Okamura – currently chief strategy officer – on 1st April.
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
